EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6605 - lysergic acid diethylamide
| Formula | C20H25N3O |
| Net Charge | 0 |
| Average Mass | 323.440 |
| Monoisotopic Mass | 323.19976 |
| SMILES | [H][C@@]12Cc3cnc4cccc(c34)C1=C[C@@H](C(=O)N(CC)CC)CN2C |
| InChI | InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1 |
| InChIKey | VAYOSLLFUXYJDT-RDTXWAMCSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. dopamine agonist A drug that binds to and activates dopamine receptors. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. dopamine agonist A drug that binds to and activates dopamine receptors. hallucinogen Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations and other alterations of mood and thinking. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lysergic acid diethylamide (CHEBI:6605) has functional parent lysergamide (CHEBI:4819) |
| lysergic acid diethylamide (CHEBI:6605) has role analgesic (CHEBI:35480) |
| lysergic acid diethylamide (CHEBI:6605) has role antidepressant (CHEBI:35469) |
| lysergic acid diethylamide (CHEBI:6605) has role anxiolytic drug (CHEBI:35474) |
| lysergic acid diethylamide (CHEBI:6605) has role dopamine agonist (CHEBI:51065) |
| lysergic acid diethylamide (CHEBI:6605) has role hallucinogen (CHEBI:35499) |
| lysergic acid diethylamide (CHEBI:6605) has role serotonergic agonist (CHEBI:35941) |
| lysergic acid diethylamide (CHEBI:6605) is a ergoline alkaloid (CHEBI:60529) |
| lysergic acid diethylamide (CHEBI:6605) is a monocarboxylic acid amide (CHEBI:29347) |
| lysergic acid diethylamide (CHEBI:6605) is a organic heterotetracyclic compound (CHEBI:38163) |
| Incoming Relation(s) |
| LSD-d3 (CHEBI:194178) has functional parent lysergic acid diethylamide (CHEBI:6605) |
| IUPAC Name |
|---|
| (8R)-9,10-didehydro-N,N-diethyl-6-methylergoline-8-carboxamide |
| INN | Source |
|---|---|
| lisergida | WHO MedNet |
| Synonyms | Source |
|---|---|
| N,N-diethyl-(+)-lysergamide | NIST Chemistry WebBook |
| N,N-diethyllysergamide | NIST Chemistry WebBook |
| N,N-diethyl-D-lysergamide | ChemIDplus |
| (+)-LSD | NIST Chemistry WebBook |
| LSD | KEGG COMPOUND |
| Lsd-25 | ChEMBL |
| Citations |
|---|